ADC Therapeutics (ADCT)
ADC Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE.
6.9M
Short interest
settlement 2026-09-30
4.4
Days to cover
+0.5 days vs prior
49.7%
Short share of volume
2026-10-23
10,900
Fails to deliver
settlement 2026-09-18
Thu 7 Jan
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in ADCT is 6,896,051 shares, up 610,087 shares over the last month. Over the last 48 readings it ranged from 3,014,605 shares (29 November 2024) to 6,896,051 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 1.6M shares a day that is 4.4 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/adct" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 6,896,051 | +27.9% | 1,579,045 | 4.37 |
| 2026-09-15 | 5,390,567 | -14.2% | 1,401,300 | 3.85 |
| 2026-08-31 | 6,285,964 | +1.8% | 2,212,555 | 2.84 |
| 2026-08-14 | 6,175,703 | +21.3% | 979,767 | 6.30 |
| 2026-07-31 | 5,092,137 | -8.0% | 834,025 | 6.11 |
| 2026-07-15 | 5,534,142 | -7.7% | 1,379,837 | 4.01 |
| 2026-06-30 | 5,993,673 | -0.2% | 1,763,741 | 3.40 |
| 2026-06-15 | 6,004,943 | -1.0% | 4,781,581 | 1.26 |
| 2026-05-29 | 6,067,857 | +5.6% | 781,868 | 7.76 |
| 2026-05-15 | 5,747,020 | +5.0% | 1,455,366 | 3.95 |
| 2026-04-30 | 5,474,173 | +6.4% | 949,468 | 5.77 |
| 2026-04-15 | 5,144,704 | +5.0% | 915,959 | 5.62 |
| 2026-03-31 | 4,901,943 | +14.3% | 782,295 | 6.27 |
| 2026-03-13 | 4,290,199 | +4.4% | 1,092,134 | 3.93 |
| 2026-02-27 | 4,108,452 | -5.8% | 920,968 | 4.46 |
| 2026-02-13 | 4,361,953 | -1.3% | 638,445 | 6.83 |
| 2026-01-30 | 4,421,340 | +15.3% | 762,272 | 5.80 |
| 2026-01-15 | 3,833,654 | +7.3% | 716,205 | 5.35 |
| 2025-12-31 | 3,573,570 | -47.2% | 1,102,854 | 3.24 |
| 2025-12-15 | 6,773,739 | +12.4% | 2,629,523 | 2.58 |
| 2025-11-28 | 6,027,937 | +2.7% | 696,331 | 8.66 |
| 2025-11-14 | 5,867,155 | -9.5% | 807,314 | 7.27 |
| 2025-10-31 | 6,480,471 | +1.7% | 721,991 | 8.98 |
| 2025-10-15 | 6,374,485 | +20.3% | 1,307,881 | 4.87 |
| 2025-09-30 | 5,298,345 | +30.2% | 1,156,022 | 4.58 |
| 2025-09-15 | 4,069,052 | -1.8% | 566,921 | 7.18 |
| 2025-08-29 | 4,143,356 | -8.2% | 717,195 | 5.78 |
| 2025-08-15 | 4,514,712 | -20.5% | 670,335 | 6.74 |
| 2025-07-31 | 5,679,129 | +3.9% | 667,518 | 8.51 |
| 2025-07-15 | 5,464,561 | +11.4% | 658,267 | 8.30 |
| 2025-06-30 | 4,906,182 | +8.3% | 1,148,394 | 4.27 |
| 2025-06-13 | 4,528,219 | +6.1% | 906,902 | 4.99 |
| 2025-05-30 | 4,267,207 | -1.4% | 880,268 | 4.85 |
| 2025-05-15 | 4,329,032 | -3.1% | 481,264 | 9.00 |
| 2025-04-30 | 4,468,234 | -1.4% | 244,559 | 18.27 |
| 2025-04-15 | 4,532,178 | +5.7% | 385,612 | 11.75 |
| 2025-03-31 | 4,287,115 | -6.1% | 366,801 | 11.69 |
| 2025-03-14 | 4,564,701 | -13.8% | 345,920 | 13.20 |
| 2025-02-28 | 5,295,877 | +8.7% | 354,358 | 14.94 |
| 2025-02-14 | 4,870,951 | +0.3% | 505,612 | 9.63 |
| 2025-01-31 | 4,857,274 | -6.2% | 507,484 | 9.57 |
| 2025-01-15 | 5,178,877 | +6.6% | 672,191 | 7.70 |
| 2024-12-31 | 4,859,104 | +17.9% | 1,029,945 | 4.72 |
| 2024-12-13 | 4,122,662 | +36.8% | 2,496,842 | 1.65 |
| 2024-11-29 | 3,014,605 | -4.7% | 450,003 | 6.70 |
| 2024-11-15 | 3,164,460 | -0.1% | 465,342 | 6.80 |
| 2024-10-31 | 3,167,562 | -9.7% | 292,792 | 10.82 |
| 2024-10-15 | 3,508,209 | -1.4% | 374,320 | 9.37 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of ADCT volume is 49.7%, down 9.1 points over the last five sessions. Over the last 30 readings it ranged from 25.6% (13 October 2026) to 73.0% (15 September 2026). The latest reading is in line with the 30-session average of 48.2%, on 334K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 166K | 334K | 49.7% | 104 |
| 2026-10-22 | 103K | 227K | 45.5% | 170 |
| 2026-10-21 | 247K | 556K | 44.5% | 151 |
| 2026-10-20 | 202K | 362K | 55.9% | 0 |
| 2026-10-19 | 90K | 216K | 41.7% | 3,471 |
| 2026-10-16 | 175K | 297K | 58.8% | 20 |
| 2026-10-15 | 204K | 495K | 41.2% | 11,911 |
| 2026-10-14 | 295K | 640K | 46.0% | 12,764 |
| 2026-10-13 | 396K | 1.5M | 25.6% | 37,410 |
| 2026-10-12 | 172K | 640K | 26.9% | 1,601 |
| 2026-10-09 | 461K | 1.2M | 37.7% | 2,130 |
| 2026-10-08 | 841K | 2.3M | 36.1% | 26,298 |
| 2026-10-07 | 309K | 784K | 39.5% | 0 |
| 2026-10-06 | 334K | 532K | 62.8% | 389 |
| 2026-10-05 | 325K | 551K | 59.1% | 0 |
| 2026-10-02 | 351K | 573K | 61.3% | 54,212 |
| 2026-10-01 | 121K | 233K | 51.8% | 38 |
| 2026-09-30 | 168K | 417K | 40.2% | 0 |
| 2026-09-29 | 192K | 292K | 65.8% | 0 |
| 2026-09-28 | 114K | 197K | 58.0% | 40 |
| 2026-09-25 | 171K | 358K | 47.8% | 1,500 |
| 2026-09-24 | 310K | 626K | 49.5% | 0 |
| 2026-09-23 | 506K | 840K | 60.3% | 0 |
| 2026-09-22 | 271K | 602K | 44.9% | 0 |
| 2026-09-21 | 290K | 839K | 34.6% | 0 |
| 2026-09-18 | 276K | 456K | 60.4% | 0 |
| 2026-09-17 | 367K | 822K | 44.6% | 0 |
| 2026-09-16 | 588K | 2.0M | 29.9% | 0 |
| 2026-09-15 | 437K | 598K | 73.0% | 0 |
| 2026-09-14 | 140K | 263K | 53.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 18 September 2026, the fails-to-deliver balance in ADCT is 10,900 shares, up 10,893 shares over the last settlement date. Over the last 30 readings it ranged from 7 shares (15 September 2026) to 1,388,213 shares (5 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-18 | 10,900 | $1.06 | $12K |
| 2026-09-15 | 7 | $1.11 | $8 |
| 2026-09-03 | 5,985 | $1.32 | $8K |
| 2026-09-02 | 27 | $1.24 | $33 |
| 2026-08-25 | 13 | $0.97 | $13 |
| 2026-08-21 | 36 | $0.96 | $35 |
| 2026-08-19 | 37 | $1.03 | $38 |
| 2026-08-11 | 8,416 | $1.13 | $10K |
| 2026-08-05 | 299,998 | $1.10 | $330K |
| 2026-07-29 | 192,489 | $1.11 | $214K |
| 2026-07-28 | 199,258 | $1.14 | $227K |
| 2026-07-27 | 199,258 | $1.15 | $229K |
| 2026-07-24 | 45,543 | $1.22 | $56K |
| 2026-07-17 | 963 | $1.35 | $1K |
| 2026-07-13 | 1,303 | $1.29 | $2K |
| 2026-07-08 | 5,126 | $1.35 | $7K |
| 2026-06-17 | 551,267 | $1.00 | $551K |
| 2026-06-16 | 659,092 | $1.05 | $692K |
| 2026-06-15 | 894,506 | $1.05 | $939K |
| 2026-06-12 | 1,025,284 | $1.06 | $1.1M |
| 2026-06-11 | 1,176,200 | $1.10 | $1.3M |
| 2026-06-10 | 1,175,440 | $1.10 | $1.3M |
| 2026-06-09 | 1,252,023 | $0.98 | $1.2M |
| 2026-06-08 | 1,380,413 | $1.03 | $1.4M |
| 2026-06-05 | 1,388,213 | $1.32 | $1.8M |
| 2026-05-01 | 788 | $3.78 | $3K |
| 2026-04-28 | 1,078 | $3.76 | $4K |
| 2026-04-17 | 790 | $4.38 | $3K |
| 2026-04-16 | 933 | $4.37 | $4K |
| 2026-04-06 | 114 | $3.78 | $431 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ADCT in the last 90 days. The most recent filings are listed below. Latest filing: Zaki Mohamed (Chief Medical Officer) on 2026-06-30.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Zaki Mohamed | Chief Medical Officer | Grant | 214K | $0.00 | $0 | 896K |
| 2026-06-30 | GRAHAM PETER J | Chief Legal Officer | Grant | 221K | $0.00 | $0 | 842K |
| 2026-06-30 | Carmona Jose | Chief Financial Officer | Grant | 204K | $0.00 | $0 | 938K |
| 2026-06-30 | MALLIK AMEET | Chief Executive Officer | Grant | 675K | $0.00 | $0 | 2.1M |
| 2026-06-03 | Azelby Robert | Director | Tax withholding | 13K | $3.08 | $39K | 113K |
| 2026-06-03 | Squarer Ron | Director | Tax withholding | 15K | $3.08 | $47K | 123K |
| 2026-06-03 | Sandor Victor | Director | Tax withholding | 13K | $3.08 | $39K | 141K |
| 2026-06-03 | Monges Viviane | Director | Tax withholding | 3K | $3.08 | $8K | 186K |
| 2026-06-03 | Hug Peter | Director | Tax withholding | 2K | $3.08 | $7K | 263K |
| 2026-06-03 | BIZZARI JEAN-PIERRE | Director | Tax withholding | 13K | $3.08 | $39K | 139K |
| 2026-06-03 | Coughlin Timothy | Director | Tax withholding | 13K | $3.08 | $39K | 72K |
| 2026-06-01 | Azelby Robert | Director | Grant | 45K | $0.00 | $0 | 125K |
| 2026-06-01 | Squarer Ron | Director | Grant | 45K | $0.00 | $0 | 139K |
| 2026-06-01 | Sandor Victor | Director | Grant | 45K | $0.00 | $0 | 153K |
| 2026-06-01 | Monges Viviane | Director | Grant | 45K | $0.00 | $0 | 189K |
| 2026-06-01 | Hug Peter | Director | Grant | 45K | $0.00 | $0 | 266K |
| 2026-06-01 | BIZZARI JEAN-PIERRE | Director | Grant | 45K | $0.00 | $0 | 152K |
| 2026-06-01 | Coughlin Timothy | Director | Grant | 45K | $0.00 | $0 | 85K |
| 2026-04-02 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 2.5M | $3.28 | $8.3M | 10.3M |
| 2026-04-02 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 2.6M | $3.28 | $8.6M | 12.7M |
| 2026-04-02 | Redmile Group, LLC | 10% owner | Sell | 2.5M | $3.28 | $8.3M | 10.3M |
| 2026-04-02 | Redmile Group, LLC | 10% owner | Sell | 2.6M | $3.28 | $8.6M | 12.7M |
| 2026-04-01 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 169K | $3.80 | $643K | 15.3M |
| 2026-04-01 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 163K | $3.80 | $618K | 12.8M |
| 2026-04-01 | Redmile Group, LLC | 10% owner | Sell | 163K | $3.80 | $617K | 12.8M |
| 2026-04-01 | Redmile Group, LLC | 10% owner | Sell | 169K | $3.80 | $643K | 15.3M |
| 2026-03-31 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 188K | $3.75 | $707K | 13.0M |
| 2026-03-31 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 196K | $3.75 | $736K | 15.5M |
| 2026-03-31 | Redmile Group, LLC | 10% owner | Sell | 188K | $3.75 | $707K | 13.0M |
| 2026-03-31 | Redmile Group, LLC | 10% owner | Sell | 196K | $3.75 | $736K | 15.5M |
| 2026-02-13 | Kallebo Lisa Michelle | Chief Accounting Officer | Tax withholding | 5K | $3.99 | $22K | 128K |
| 2026-02-13 | Kallebo Lisa Michelle | Chief Accounting Officer | Grant | 63K | $3.99 | $251K | 134K |
| 2026-02-13 | Zaki Mohamed | Chief Medical Officer | Tax withholding | 25K | $3.99 | $98K | 682K |
| 2026-02-13 | Zaki Mohamed | Chief Medical Officer | Grant | 285K | $3.99 | $1.1M | 707K |
| 2026-02-13 | GRAHAM PETER J | Chief Legal Officer | Tax withholding | 33K | $3.99 | $133K | 621K |
| 2026-02-13 | GRAHAM PETER J | Chief Legal Officer | Grant | 295K | $3.99 | $1.2M | 654K |
| 2026-02-13 | Carmona Jose | Chief Financial Officer | Tax withholding | 26K | $3.99 | $103K | 734K |
| 2026-02-13 | Carmona Jose | Chief Financial Officer | Grant | 272K | $3.99 | $1.1M | 760K |
| 2026-02-13 | MALLIK AMEET | Chief Executive Officer | Tax withholding | 103K | $3.99 | $412K | 1.4M |
| 2026-02-13 | MALLIK AMEET | Chief Executive Officer | Grant | 900K | $3.99 | $3.6M | 1.6M |
| 2025-12-06 | MALLIK AMEET | Chief Executive Officer | Tax withholding | 233K | $3.29 | $767K | 1.3M |
| 2025-12-06 | Zaki Mohamed | Chief Medical Officer | Tax withholding | 41K | $3.29 | $135K | 422K |
| 2025-12-06 | Kallebo Lisa Michelle | Chief Accounting Officer | Tax withholding | 7K | $3.29 | $23K | 71K |
| 2025-12-06 | GRAHAM PETER J | Chief Legal Officer | Tax withholding | 50K | $3.29 | $163K | 359K |
| 2025-12-06 | Carmona Jose | Chief Financial Officer | Tax withholding | 53K | $3.29 | $175K | 489K |
| 2025-06-13 | Squarer Ron | Director | Tax withholding | 15K | $3.58 | $54K | 94K |
| 2025-06-13 | Sandor Victor | Director | Tax withholding | 13K | $3.58 | $45K | 108K |
| 2025-06-13 | Monges Viviane | Director | Tax withholding | 3K | $3.58 | $9K | 144K |
| 2025-06-13 | Hug Peter | Director | Tax withholding | 2K | $3.58 | $8K | 221K |
| 2025-06-13 | BIZZARI JEAN-PIERRE | Director | Tax withholding | 13K | $3.58 | $45K | 107K |
| 2025-06-13 | Azelby Robert | Director | Tax withholding | 13K | $3.58 | $45K | 80K |
| 2025-06-03 | Squarer Ron | Director | Grant | 40K | $0.00 | $0 | 109K |
| 2025-06-03 | Monges Viviane | Director | Grant | 40K | $0.00 | $0 | 147K |
| 2025-06-03 | Hug Peter | Director | Grant | 40K | $0.00 | $0 | 223K |
| 2025-06-03 | BIZZARI JEAN-PIERRE | Director | Grant | 40K | $0.00 | $0 | 120K |
| 2025-06-03 | Azelby Robert | Director | Grant | 40K | $0.00 | $0 | 93K |
| 2025-06-03 | Sandor Victor | Director | Grant | 40K | $0.00 | $0 | 121K |
| 2025-06-03 | COUGHLIN TIMOTHY | Director | Grant | 40K | $0.00 | $0 | 40K |
| 2025-05-15 | Pfisterer Thomas | Other | Other transaction | 452K | price not stated in the filing | not stated | 174K |
| 2025-05-15 | WILD HANS PETER | TenPercentOwner | Other transaction | 9.8M | price not stated in the filing | not stated | 9.8M |
| 2025-05-06 | MALLIK AMEET | Chief Executive Officer | Tax withholding | 27K | $1.29 | $35K | 1.6M |
| 2025-02-13 | MALLIK AMEET | Chief Executive Officer | Grant | 650K | $1.61 | $1.0M | 1.6M |
| 2025-02-13 | Carmona Jose | Chief Financial Officer | Grant | 240K | $1.61 | $386K | 542K |
| 2025-02-13 | Kallebo Lisa Michelle | Chief Accounting Officer | Grant | 42K | $1.61 | $67K | 78K |
| 2025-02-13 | Zaki Mohamed | Chief Medical Officer | Grant | 230K | $1.61 | $370K | 463K |
| 2025-02-13 | GRAHAM PETER J | Chief Legal Officer | Grant | 220K | $1.61 | $354K | 409K |
| 2024-12-11 | Green Jeremy | TenPercentOwner | Buy | 50K | $2.28 | $114K | 13.1M |
| 2024-12-06 | MALLIK AMEET | Chief Executive Officer | Tax withholding | 238K | $3.13 | $746K | 929K |
| 2024-12-06 | GRAHAM PETER J | Chief Legal Officer | Tax withholding | 41K | $3.13 | $130K | 189K |
| 2024-12-06 | Carmona Jose | Chief Financial Officer | Tax withholding | 48K | $3.13 | $151K | 302K |
| 2024-12-06 | Kallebo Lisa Michelle | Chief Accounting Officer | Tax withholding | 7K | $3.13 | $20K | 36K |
| 2024-12-06 | Zaki Mohamed | Chief Medical Officer | Tax withholding | 37K | $3.13 | $116K | 233K |
| 2024-12-04 | RedCo II Master Fund, L.P. | TenPercentOwner | Other transaction | 51K | $2.07 | $105K | 15.6M |
| 2024-12-04 | RedCo II Master Fund, L.P. | TenPercentOwner | Sell | 25K | $2.07 | $52K | 15.6M |
| 2024-07-01 | RedCo II Master Fund, L.P. | TenPercentOwner | Buy | 400K | $2.81 | $1.1M | 13.0M |
| 2024-06-17 | Squarer Ron | Director | Sell | 7K | $2.89 | $20K | 81K |
| 2024-06-17 | Sandor Victor | Director | Sell | 7K | $2.89 | $20K | 81K |
| 2024-06-17 | Pfisterer Thomas | Director | Sell | 1K | $2.89 | $4K | 214K |
| 2024-06-17 | Monges Viviane | Director | Sell | 1K | $2.89 | $4K | 107K |
| 2024-06-17 | Hug Peter | Director | Sell | 1K | $2.89 | $3K | 183K |
| 2024-06-17 | BIZZARI JEAN-PIERRE | Director | Sell | 7K | $2.89 | $20K | 80K |
| 2024-06-17 | Azelby Robert | Director | Sell | 7K | $2.89 | $20K | 53K |
| 2024-06-13 | Monges Viviane | Director | Grant | 40K | $0.00 | $0 | 108K |
| 2024-06-13 | Squarer Ron | Director | Grant | 40K | $0.00 | $0 | 88K |
| 2024-06-13 | Sandor Victor | Director | Grant | 40K | $0.00 | $0 | 88K |
| 2024-06-13 | Pfisterer Thomas | Director | Grant | 40K | $0.00 | $0 | 215K |
| 2024-06-13 | Hug Peter | Director | Grant | 40K | $0.00 | $0 | 184K |
| 2024-06-13 | BIZZARI JEAN-PIERRE | Director | Grant | 40K | $0.00 | $0 | 86K |
| 2024-06-13 | Azelby Robert | Director | Grant | 40K | $0.00 | $0 | 60K |
| 2024-05-07 | MALLIK AMEET | Chief Executive Officer | Sell | 30K | $4.48 | $133K | 1.2M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON13 holders report 5% or more of ADCT in their latest filing, all on Schedule 13G (passive). The largest reported stake is Redmile Group, LLC at 9.9% of the class (12,717,487 shares), filed 2026-04-24 for an event on 2026-04-20.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G | Wilmot B. Harkeyparent holding company | 12.3M | 9.7% | 2026-06-30 |
| 2026-08-14 | 13G | Nantahala Capital Management, LLCinvestment adviser | 12.3M | 9.7% | 2026-06-30 |
| 2026-08-14 | 13G | Daniel Mackparent holding company | 12.3M | 9.7% | 2026-06-30 |
| 2026-07-27 | 13G | BlackRock, Inc.parent holding company | 6.9M | 5.4% | 2026-06-30 |
| 2026-04-24 | 13G/Ano. 8 | Redmile Group, LLCinvestment adviser, other entity | 12.7M | 9.9% | 2026-04-20 |
| 2026-04-24 | 13G/Ano. 8 | Jeremy C. Greenparent holding company, individual | 12.7M | 9.9% | 2026-04-20 |
| 2026-04-24 | 13G/Ano. 8 | RedCo II Offshore SPV LLCnon-US institution, other entity | 7.8M | 6.1% | 2026-04-20 |
| 2026-04-24 | 13G/Ano. 8 | RedCo II Master Fund, L.P.partnership, non-US institution | 0 | 0.0% | 2026-04-20 |
| 2026-02-17 | 13G/Ano. 1 | ORBIMED CAPITAL LLCinvestment adviser | 3.2M | 2.6% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | ORBIMED ADVISORS LLCinvestment adviser | 2.6M | 2.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Steven A. Cohenindividual | 5.0M | 4.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 5.0M | 4.0% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 5.0M | 4.0% | 2025-12-31 |
| 2026-02-17 | 13G | Chen Yuindividual | 11.4M | 9.2% | 2025-10-27 |
| 2026-02-17 | 13G | TCG Crossover GP II, LLCother entity | 11.4M | 9.2% | 2025-10-27 |
| 2026-02-17 | 13G | TCG Crossover Fund II, L.P.partnership | 11.4M | 9.2% | 2025-10-27 |
| 2026-02-13 | 13G/Ano. 4 | W. Lawrence Hawkinsparent holding company, individual | 8.5M | 6.8% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 4 | Prosight Management, LPinvestment adviser | 8.5M | 6.8% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 4 | Prosight Partners, LLCother entity | 8.5M | 6.8% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 4 | Prosight Plus Fund, LPpartnership | 1.8M | 1.5% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 4 | Prosight Fund, LPpartnership | 402K | 0.3% | 2025-12-31 |
| 2025-11-05 | 13G/Ano. 1 | Oaktree Fund Administration, LLCother entity | 4.7M | 4.1% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Oaktree Capital Holdings, LLCother entity | 4.7M | 4.1% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Oaktree Capital Group Holdings GP, LLCother entity | 4.7M | 4.1% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Brookfield Asset Management ULCother entity | 0 | 0.0% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Brookfield Corporationother entity | 0 | 0.0% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Brookfield Asset Management, Ltd.other entity | 0 | 0.0% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | BAM Partners Trustother entity | 0 | 0.0% | 2025-09-30 |
13F holders
Tracked managers holding ADCT at their latest 13F. JSON6 of the 30 tracked managers held ADCT at their latest 13F, $11.5M in total at quarter-end prices. Point72 Asset Management is the largest at $3.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 3.6M | $3.9M | 0.00% | +267K |
| Millennium Management | 2026-06-30 | 2.9M | $3.1M | 0.00% | -220K |
| Citadel Advisors | 2026-06-30 | 2.1M | $2.2M | 0.00% | +1.7M |
| Two Sigma Investments | 2026-06-30 | 773K | $828K | 0.00% | +105K |
| D. E. Shaw & Co. | 2026-06-30 | 719K | $770K | 0.00% | +476K |
| AQR Capital Management | 2026-06-30 | 658K | $704K | 0.00% | +420K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
ADC Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows ADC Therapeutics (ADCT), SEC CIK 1771910, listed on NYSE. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-18.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-30.JSON and CSV
- Company record
- EDGAR filing index for CIK 1771910Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- MLMMartin Marietta Materials
- MMM3M
- MNSTMonster Beverage
- MOAltria Group
- MODModine Manufacturing
- MOSMosaic
- MPMP Materials
- MPCMarathon Petroleum
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
- MTSIMACOM Technology Solutions Holdings
- MTZMasTec
Datasets
Frequently Asked Questions
How much of ADCT is sold short?
6,896,051 shares were held short at the 2026-09-30 settlement, 4.4 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ADCT's daily short volume?
On 2026-10-23, 166,209 of the 334,168 ADCT shares reported to FINRA were sold short, 49.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ADCT have fails to deliver?
The SEC's latest file shows 10,900 ADCT shares failed to deliver at settlement 2026-09-18. Fails are reported per settlement date and published twice a month with a lag.
Are ADCT insiders buying or selling?
No open-market insider trades were reported for ADCT in the last 90 days. The most recent filings are listed below. Latest filing: Zaki Mohamed (Chief Medical Officer) on 2026-06-30.
Who owns 5% or more of ADCT?
13 holders report 5% or more of ADCT in their latest filing, all on Schedule 13G (passive). The largest reported stake is Redmile Group, LLC at 9.9% of the class (12,717,487 shares), filed 2026-04-24 for an event on 2026-04-20.
Which tracked 13F managers own ADCT?
6 of the 30 tracked 13F managers held ADCT shares at their latest filing, $11.5M in all. The largest: Steve Cohen's Point72 Asset Management (3.6M shares, $3.9M), Izzy Englander's Millennium Management (2.9M shares, $3.1M), Ken Griffin's Citadel Advisors (2.1M shares, $2.2M), Two Sigma Investments (773K shares, $828K), D. E. Shaw & Co. (719K shares, $770K), Cliff Asness's AQR Capital Management (658K shares, $704K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.